[X18!] Rebirth Champions X vs Build Elevator to Skydive
Build Elevator to Skydive currently leads with 21 concurrent players against 14, a 1.5× advantage. On all-time peak the record belongs to Build Elevator to Skydive at 35 concurrent players, versus 33. Lifetime, [X18!] Rebirth Champions X has more visits (138.9M vs 560.3K). Full side-by-side history for [X18!] Rebirth Champions X and Build Elevator to Skydive is charted above.
[🍀X18!] Rebirth Champions X
14
playing now
29 24h peak · 138.9M visits
VS
Build Elevator to Skydive 🪂
21
playing now
35 24h peak · 560.3K visits
Player count history
[X18!] Rebirth Champions XBuild Elevator to Skydive
Head to head
| Metric | [X18!] Rebirth Champions X | Build Elevator to Skydive | Difference |
|---|---|---|---|
| Playing now | 14 | 21 | 7 (1.5×) |
| 24h peak | 29 | 35 | 6 |
| 24h average | 18 | 16 | 2 |
| 7-day peak | 32 | 35 | 3 |
| 7-day average | 22 | 9 | 13 (2.4×) |
| 30-day peak | 32 | 35 | 3 |
| All-time peak | 33 | 35 | 2 |
| 24h change | ▼ 10.0% | ▲ 77.8% | — |
| 7d change | — | ▲ 800.0% | — |
| Total visits | 138.9M | 560.3K | 138.3M (247.9×) |
| Visits (24h) | 1.1K | 2.7K | 1.6K (2.5×) |
| Visits (7d) | 7.2K | 11.3K | 4K (1.6×) |
| Favorites | 335.2K | 1.5K | 333.7K (219.0×) |
| Rating | 95.6% | 62.7% | — |
| Global rank (players) | #4,683 | #4,494 | of 7,126 |
| Trending score | -12.3 | 29.1 | — |
| Created | Jan 14, 2022 | Jan 22, 2026 | — |
| Genre | Simulation | Simulation | — |
Other comparisons
[X18!] Rebirth Champions X vs RO-Wizard[X18!] Rebirth Champions X vs MY AVATAR SHOP[X18!] Rebirth Champions X vs Twisted Legacy[X18!] Rebirth Champions X vs Truss Per Difficulty Chart Obby[X18!] Rebirth Champions X vs Five Nights at Freddy's 2[X18!] Rebirth Champions X vs Print Money TycoonCompare two other games →
Both games are sampled on the same schedule and plotted on a shared time axis, so the comparison is like for like. Peaks, averages and growth come from RoVitals's own recorded history — 6 days for [X18!] Rebirth Champions X, 8 for Build Elevator to Skydive.